| 000 | 01606 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515061040.0 | ||
| 264 | 0 | _c20070620 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1016/j.bbrc.2007.02.087 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobison, A J | |
| 245 | 0 | 0 |
_aOxidation of calmodulin alters activation and regulation of CaMKII. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cApr 2007 |
||
| 300 |
_a97-101 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aCalcium-Calmodulin-Dependent Protein Kinase Type 2 |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xgenetics |
| 650 | 0 | 4 |
_aCalmodulin _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 |
_aMagnesium _xpharmacology |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xmetabolism |
| 700 | 1 | _aWinder, Danny G | |
| 700 | 1 | _aColbran, Roger J | |
| 700 | 1 | _aBartlett, Ryan K | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 356 _gno. 1 _gp. 97-101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2007.02.087 _zAvailable from publisher's website |
| 999 |
_c16900514 _d16900514 |
||